Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001082813 | SCV000290130 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000227489 | SCV000312489 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002311355 | SCV000846587 | benign | Inborn genetic diseases | 2016-04-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001082813 | SCV001834498 | benign | not provided | 2018-07-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003457656 | SCV004180601 | benign | Developmental and epileptic encephalopathy, 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001082813 | SCV001799419 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000227489 | SCV001932444 | benign | not specified | no assertion criteria provided | clinical testing |